Booth Michael J, Clauw Daniel, Janevic Mary R, Kobayashi Lindsay C, Piette John D
University of Michigan, Ann Arbor, Michigan.
University of Michigan and Veterans Affairs Center for Clinical Management Research, Ann Arbor, Michigan.
ACR Open Rheumatol. 2021 Apr;3(4):239-249. doi: 10.1002/acr2.11229. Epub 2021 Feb 23.
To determine the validity of self-reported physician diagnosis of rheumatoid arthritis (RA) using multiple gold-standard measures based on Medicare claims in a nationally representative sample of older adults and to verify whether additional questions about taking medication and having seen a physician in the past two years for arthritis can improve the positive predictive value (PPV) and other measures of the validity of self-reported RA.
A total of 3768 Medicare-eligible respondents with and without incident self-reported RA were identified from the 2004, 2008, and 2012 waves of the United States Health and Retirement Study. Self-reported RA was validated using the following three claims-based algorithms: 1) a single International Classification of Diseases, ninth edition, Clinical Modification claim for RA, 2) two or more claims no greater than 2 years apart, and 3) two or more claims with at least one diagnosis by a rheumatologist. Additional self-report questions of medication use and having seen a doctor for arthritis in the past two years were validated against the same criteria.
A total of 345 respondents self-reported a physician diagnosis of RA. Across all three RA algorithms, the PPV of self-report ranged from 0.05 to 0.16., the sensitivity ranged from 0.23 to 0.55., and the κ statistic ranged from 0.07 to 0.15. Additional self-report data regarding arthritis care improved the PPV and other validity measures of self-report; however, the values remained low.
Most older adults who self-report RA do not have a Medicare claims history consistent with that diagnosis. Revisions to current self-reported RA questions may yield more valid identification of RA in national health surveys.
在具有全国代表性的老年人样本中,使用基于医疗保险理赔数据的多种金标准测量方法来确定自我报告的类风湿性关节炎(RA)医生诊断的有效性,并验证关于过去两年内服用药物和因关节炎看过医生的其他问题是否能提高自我报告RA的阳性预测值(PPV)及其他有效性测量指标。
从2004年、2008年和2012年的美国健康与退休研究中,共识别出3768名符合医疗保险资格且有或无自我报告新发RA的受访者。使用以下三种基于理赔数据的算法对自我报告的RA进行验证:1)一份国际疾病分类第九版临床修订版的RA理赔记录;2)两份或更多间隔不超过2年的理赔记录;3)两份或更多理赔记录且至少有一次由风湿病学家做出的诊断。针对相同标准,对过去两年内药物使用和因关节炎看过医生的其他自我报告问题进行验证。
共有345名受访者自我报告医生诊断为RA。在所有三种RA算法中,自我报告的PPV范围为0.05至0.16,敏感性范围为0.23至0.55,κ统计量范围为0.07至0.15。关于关节炎护理的额外自我报告数据改善了自我报告的PPV和其他有效性测量指标;然而,这些值仍然较低。
大多数自我报告患有RA的老年人没有与该诊断相符的医疗保险理赔记录。对当前自我报告的RA问题进行修订可能会在全国健康调查中更有效地识别RA。